About CardioFocus
CardioFocus is a private company based in Marlborough, Massachusetts. It has reported $153,218,525 raised in 13 offerings on Form D since June 2009.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 8, 2023 | Feb 24, 2023 | $27,155,857of $31.7M target | 4 | $6.7M | Equity, DebtRule 506(b) | Form D ↗ |
| Mar 30, 2022 | Apr 12, 2022 | $3,999,998of $49.9M target | 12 | $333K | EquityRule 506(b) | Form D ↗ |
| Jul 7, 2020 | Jul 20, 2020 | $12,020,000of $15.0M target | 13 | $924K | EquityRule 506(b) | Form D ↗ |
| May 9, 2019 | May 20, 2019 | $8,000,000of $12.0M target | 17 | $470K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Apr 4, 2018 | Apr 18, 2018amended Apr 18, 2018 | $13,000,000of $21.0M target | 1 | $13.0M | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Feb 15, 2017 | Mar 1, 2017 | $20,178,554of $32.0M target | 26 | $776K | Equity, OptionsRule 506(b) | Form D ↗ |
| May 11, 2016 | May 18, 2016 | $8,000,000of $12.0M target | 0 | — | Equity, Debt, CONVERTIBLE DEBTRule 506(b) | Form D ↗ |
| Dec 22, 2014 | Jan 6, 2015 | $31,652,646of $33.2M target | 32 | $989K | Equity, Preferred Stock can convert to Common Stock.Rule 506(b) | Form D ↗ |
| Nov 7, 2014 | Nov 13, 2014 | $2,300,000fully sold | 29 | $79,310 | Equity, Debt, Convertible debtRule 506(b) | Form D ↗ |
| Apr 29, 2014 | May 9, 2014 | $2,378,923of $5.0M target | 27 | $88,108 | Equity, Debt, Convertible DebtRule 506(b) | Form D ↗ |
| Feb 10, 2011 | Feb 24, 2011 | $13,639,082of $15.6M target | 25 | $545K | Equity06 | Form D ↗ |
| Apr 8, 2010 | Apr 20, 2010 | $5,000,000fully sold | 13 | $384K | Equity, Debt, Options06 | Form D ↗ |
| Jun 15, 2009 | Jun 25, 2009 | $5,893,465of $9.2M target | 19 | $310K | Debt, Options06 | Form D ↗ |
| Total, 13 offerings | $153,218,525 | |||||
The filing for the offering first filed May 18, 2016 reports amount sold with no investors. Figures are shown as filed.
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on CardioFocus's Form D filed Feb 24, 2023.
Earlier filings also listed Paul LaViolette (director, last listed Apr 2022), Patrick Wethington (director, last listed Apr 2022), Omar Amirana (director, last listed Apr 2022), Burke Barrett (ceo & president, director, last listed Apr 2022), Omari Bouknight (executive officer, last listed May 2019), Greg Madden (director, last listed May 2019), Christopher Kroeger (director, last listed May 2019) and Warren Clark, III (cfo, last listed Apr 2018).